STAT+: A bet on baldness

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning! Join us later today for a virtual event with STAT’s Jason Mast and Damian Garde about the past and future of Moderna — once one of biotech’s most secretive startups and now, well, pretty well known!

Also, more on the contentious Metsera deal, and a look at the newly sprouting sector of hair regrowth.

Continue to STAT+ to read the full story…

​STAT Pharma: The science and business of new drug development

Leave a Reply

Your email address will not be published. Required fields are marked *